Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Lung Neoplasms 10Carcinoma, Non-Small-Cell Lung 9Fallopian Tube Neoplasms 7Ovarian Neoplasms 6Colorectal Neoplasms 5Urinary Bladder Neoplasms 4Pancreatic Neoplasms 4Melanoma 4Carcinoma, Hepatocellular 4Glioblastoma 3Colonic Neoplasms 3Carcinoma, Renal Cell 3Brain Neoplasms 3Urethral Neoplasms 2Ureteral Neoplasms 2Thyroid Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Rectal Neoplasms 2Prostatic Neoplasms 2Neoplasm Metastasis 2Nasopharyngeal Carcinoma 2Multiple Myeloma 2Lymphoma, Large B-Cell, Diffuse 2Lymphoid Interstitial Pneumonia 2Liposarcoma 2Carcinoma, Neuroendocrine 2Carcinoma 2Brenner Tumor 2Breast Neoplasms 2Adenocarcinoma, Mucinous 2

Interventions

Temozolomide 7Radiotherapy 6Specimen Handling 5Magnetic Resonance Spectroscopy 5Radiation 4Radiotherapy, Intensity-Modulated 2Nivolumab 2vorasidenib 1veliparib 1trametinib 1tocilizumab 1pembrolizumab 1fimepinostat 1dabrafenib 1atezolizumab 1abemaciclib 1Vorinostat 1Vincristine 1Spinal Puncture 1Radiotherapy, Conformal 1Protons 1Proton Therapy 1Procarbazine 1OKN 007 1Mycophenolic Acid 1Lomustine 1Irinotecan 1Ipilimumab 1Immunoglobulin G 1Disulfides 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Astrocytoma × Immunoglobulin G × Clear all
NCT04729959 2026-04-01

Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma

National Cancer Institute (NCI)

Phase 2 Active not recruiting
59 enrolled
CNS

Astrocytoma, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡